Literature DB >> 11080679

Roles of secretory phospholipases A(2) in inflammatory diseases and trauma.

T J Nevalainen1, M M Haapamäki, J M Grönroos.   

Abstract

Six distinct secretory small molecular weight phospholipases A(2) (PLA(2)) have been cloned and characterized from human tissues. Two of them, pancreatic group IB PLA(2) (PLA(2)-IB) and synovial-type group IIA PLA(2) (PLA(2)-IIA) have been studied as to their association to various inflammatory diseases. PLA(2)-IB is a digestive enzyme synthesized by pancreatic acinar cells. In acute pancreatitis, which is characterized by destruction of pancreatic tissue, PLA(2)-IB is released into the circulation, but its role in pancreatic and other tissue damage is still hypothetical. The concentration of PLA(2)-IIA increases in blood plasma in generalized inflammatory response resulting from infections, chronic inflammatory diseases, acute pancreatitis, trauma and surgical operations. PLA(2)-IIA is synthesized in a number of gland cells and is present in cellular secretions on mucosal surfaces including Paneth cells of intestinal mucosa, prostatic gland cells and seminal plasma, and lacrimal glands and tears. PLA(2)-IIA is expressed in hepatoma-derived cells in vitro and hepatocytes in vivo. PLA(2)-IIA is regarded as an acute phase protein and seems to function as an antibacterial agent especially effective against Gram-positive bacteria. Other putative functions in the inflammatory reaction include hydrolysis of cell membrane phospholipids and release of arachidonic acid for prostanoid synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080679     DOI: 10.1016/s1388-1981(00)00112-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

1.  Biochemical parameters of bronchoalveolar lavage fluid in fat embolism.

Authors:  Georgia Karagiorga; George Nakos; Eftychia Galiatsou; Marilena E Lekka
Journal:  Intensive Care Med       Date:  2005-12-02       Impact factor: 17.440

2.  Role of sphingomyelin and ceramide in the regulation of the activity and fatty acid specificity of group V secretory phospholipase A2.

Authors:  Dev K Singh; Laurence R Gesquiere; Papasani V Subbaiah
Journal:  Arch Biochem Biophys       Date:  2006-11-21       Impact factor: 4.013

3.  Chronic intracerebroventricular delivery of the secretory phospholipase A2 inhibitor, 12-epi-scalaradial, does not improve outcome after focal cerebral ischemia-reperfusion in rats.

Authors:  Germán Torregrosa; Fernando J Pérez-Asensio; María C Burguete; María Castelló-Ruiz; Juan B Salom; Enrique Alborch
Journal:  Exp Brain Res       Date:  2007-01       Impact factor: 1.972

Review 4.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

5.  Protective effects and mechanisms of Baicalin and octreotide on renal injury of rats with severe acute pancreatitis.

Authors:  Xi-Ping Zhang; Hua Tian; Yue-Hong Lai; Li Chen; Ling Zhang; Qi-Hui Cheng; Wei Yan; Yun Li; Qing-Yu Li; Qing He; Fei Wang
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

6.  Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.

Authors:  Rob C Oslund; Nathan Cermak; Christophe L M J Verlinde; Michael H Gelb
Journal:  Bioorg Med Chem Lett       Date:  2008-09-12       Impact factor: 2.823

7.  Expression profiling reveals novel innate and inflammatory responses in the jejunal epithelial compartment during infection with Trichinella spiralis.

Authors:  Pamela A Knight; Alan D Pemberton; Kevin A Robertson; Douglas J Roy; Steven H Wright; Hugh R P Miller
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Evolution of a rippled membrane during phospholipase A2 hydrolysis studied by time-resolved AFM.

Authors:  Chad Leidy; Ole G Mouritsen; Kent Jørgensen; Günther H Peters
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

9.  Synthesis of oligo(ethylene glycol) substituted phosphatidylcholines: secretory PLA2-targeted precursors of NSAID prodrugs.

Authors:  Renato Rosseto; Joseph Hajdu
Journal:  Chem Phys Lipids       Date:  2010-01       Impact factor: 3.329

10.  Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3.

Authors:  Tomaz Koprivnjak; Christopher Weidenmaier; Andreas Peschel; Jerrold P Weiss
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.